Table 1.
Variables | Whole dataset | COVID– (n = 10) | COVID+ (n = 13) |
---|---|---|---|
Sex male | 20 (87%) | 8 (80%) | 12 (92%) |
Age (yr) | 62 ± 15 | 60 ± 15 | 64 ± 15 |
Height (cm) | 170 ± 11 | 170 ± 14 | 170 ± 9 |
BMI (kg.m−2) | 30 ± 6 | 30 ± 8 | 29 ± 5 |
Delay between ICU admission and inclusion (day) | 2 ± 2 | 2 ± 2 | 2 ± 2 |
Delay between inclusion and ARDS onset (day) | 1 ± 1 | 1 ± 1 | 1 ± 1 |
SAPS 2 at ICU admission | 42 ± 15 | 49 ± 18 | 38 ± 12 |
SOFA score at inclusion | 12 ± 3 | 13 ± 3 | 11 ± 2a |
ARDS risk factor | |||
|
20 (87%) | 7 (70%) | 13 (100%) |
|
3 (13%) | 3 (30%) | 0 (0%) |
ARDS severity | |||
|
12 (52%) | 3 (30%) | 9 (69%) |
|
11 (48%) | 7 (70%) | 4 (31%) |
Prone position | 15 (65%) | 7 (70%) | 8 (62%) |
NMBA | 23 (100%) | 10 (100%) | 13 (100%) |
RRT | 0 (0%) | 0 (0%) | 0 (0%) |
Inotropes administration | 0 (0%) | 0 (0%) | 0 (0%) |
Vasopressor administration | 19 (83%) | 8 (80%) | 11 (85%) |
Values are mean ± standard deviation or count (percentage).
ARDS = acute respiratory distress syndrome; BMI = body mass index; COVID− = non-COVID-19 ARDS patients; COVID+ = COVID-19 ARDS patients; ICU = intensive care unit; NMBA = neuromuscular blocking agents; RRT = renal replacement therapy; SAPS2 = simplified acute physiology score.
p < 0.05 between groups.